BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21999842)

  • 1. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.
    Ummanni R; Jost E; Braig M; Lohmann F; Mundt F; Barett C; Schlomm T; Sauter G; Senff T; Bokemeyer C; Sültmann H; Meyer-Schwesinger C; Brümmendorf TH; Balabanov S
    Mol Cancer; 2011 Oct; 10():129. PubMed ID: 21999842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma.
    Li L; Tao Q; Jin H; van Hasselt A; Poon FF; Wang X; Zeng MS; Jia WH; Zeng YX; Chan AT; Cao Y
    Clin Cancer Res; 2010 Jun; 16(11):2949-58. PubMed ID: 20395212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ubiquitin peptidase UCHL1 induces G0/G1 cell cycle arrest and apoptosis through stabilizing p53 and is frequently silenced in breast cancer.
    Xiang T; Li L; Yin X; Yuan C; Tan C; Su X; Xiong L; Putti TC; Oberst M; Kelly K; Ren G; Tao Q
    PLoS One; 2012; 7(1):e29783. PubMed ID: 22279545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of hypermethylation in promoter region of ubiquitin carboxyl-terminal hydrolase L1 in human esophageal cancer].
    Yan WJ; Guo MZ; Yang YS
    Zhonghua Nei Ke Za Zhi; 2012 May; 51(5):390-3. PubMed ID: 22883340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma.
    Seliger B; Handke D; Schabel E; Bukur J; Lichtenfels R; Dammann R
    J Transl Med; 2009 Oct; 7():90. PubMed ID: 19857250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous expression and functional relevance of the ubiquitin carboxyl-terminal hydrolase L1 in melanoma.
    Wulfänger J; Biehl K; Tetzner A; Wild P; Ikenberg K; Meyer S; Seliger B
    Int J Cancer; 2013 Dec; 133(11):2522-32. PubMed ID: 23686552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) in sporadic and hereditary Tunisian breast cancer patients: clinical significance.
    Trifa F; Karray-Chouayekh S; Jmaa ZB; Jmal E; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Med Oncol; 2013 Mar; 30(1):418. PubMed ID: 23315218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.
    Abdelmaksoud-Dammak R; Saadallah-Kallel A; Miladi-Abdennadher I; Ayedi L; Khabir A; Sallemi-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2016 Feb; 37(2):1707-14. PubMed ID: 26314856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma.
    Zheng S; Qiao G; Min D; Zhang Z; Lin F; Yang Q; Feng T; Tang L; Sun Y; Zhao H; Li H; Yu W; Yang Y; Shen Z; Yao Y
    Cancer Lett; 2015 Apr; 359(1):36-46. PubMed ID: 25578779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.
    Kato N; Yamamoto H; Adachi Y; Ohashi H; Taniguchi H; Suzuki H; Nakazawa M; Kaneto H; Sasaki S; Imai K; Shinomura Y
    World J Gastroenterol; 2013 Mar; 19(11):1718-27. PubMed ID: 23555160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of HTATIP2 and UCHL1 as a predictive biomarker for cholangiocarcinoma.
    Nanok C; Jearanaikoon P; Proungvitaya S; Limpaiboon T
    Mol Med Rep; 2018 Mar; 17(3):4145-4153. PubMed ID: 29359783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
    Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
    Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
    Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
    Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
    Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
    Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation of
    Zhao Y; Lei Y; He SW; Li YQ; Wang YQ; Hong XH; Liang YL; Li JY; Chen Y; Luo WJ; Zhang PP; Yang XJ; He QM; Ma J; Liu N; Tang LL
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
    Fukutomi S; Seki N; Koda K; Miyazaki M
    Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of silenced UCHL1 and IGFBP4 expression suppresses clonogenicity of giant cell tumor-derived stromal cells.
    Fellenberg J; Sähr H; Liu L; Schönsiegel F; Depeweg D; Lehner B; Herr I
    Cancer Lett; 2013 Aug; 336(1):61-7. PubMed ID: 23603559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation.
    Lynch RL; Konicek BW; McNulty AM; Hanna KR; Lewis JE; Neubauer BL; Graff JR
    Mol Cancer Res; 2005 Mar; 3(3):163-9. PubMed ID: 15798096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of N-myc downstream regulated gene 1 caused by the methylation of CpG islands of NDRG1 promoter promotes proliferation and invasion of prostate cancer cells.
    Li Y; Pan P; Qiao P; Liu R
    Int J Oncol; 2015 Sep; 47(3):1001-8. PubMed ID: 26202882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.